County of Ventura
County of Ventura was paid $14.53M by Medicaid between Jan 2018 and Dec 2024, across 127 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 62% of everything it billed.
VENTURA, CA 93001
Next to other Federally Qualified Health Center (FQHC) providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,790 | $2.32M | |
| 2019 | 45,712 | $1.30M | |
| 2020 | 56,512 | $1.66M | |
| 2021 | 57,492 | $1.86M | |
| 2022 | 53,244 | $2.09M | |
| 2023 | 61,285 | $2.50M | |
| 2024incomplete | 46,870 | $2.80M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 62% | 104,518 | 93,843 | $9.01M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 9.5% | 2,368 | 2,367 | $1.38M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.1% | 81,592 | 74,462 | $746K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.0% | 28,843 | 27,101 | $578K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.2% | 10,398 | 10,340 | $469K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.4% | 5,935 | 5,916 | $342K |
| 64615 | 1.3% | 2,307 | 2,289 | $187K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.1% | 2,039 | 2,035 | $157K |
| 95886 | <1% | 2,012 | 1,008 | $135K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,409 | 1,369 | $102K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 4,616 | 4,322 | $100K |
| 59425 | <1% | 1,346 | 842 | $99K |
115 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 31,650 | $79K |
| G0467 | Community health center visit, returning patient | <1% | 19,557 | $69K |
| 90686 | <1% | 6,199 | $67K | |
| 99406 | <1% | 8,898 | $67K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,065 | $60K |
| 90715 | <1% | 1,747 | $49K | |
| 25600 | <1% | 236 | $48K | |
| 90750 | <1% | 388 | $47K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,036 | $46K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,424 | $45K |
| 20553 | <1% | 783 | $41K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 528 | $40K |
| 76942 | <1% | 1,786 | $38K | |
| 99245 | <1% | 244 | $29K | |
| 29075 | <1% | 332 | $29K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,635 | $28K |
| 73610 | <1% | 1,092 | $23K | |
| 99243 | <1% | 305 | $23K | |
| 92551 | <1% | 3,724 | $19K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 730 | $18K |
| 90677 | <1% | 187 | $17K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 6,042 | $17K |
| 73620 | <1% | 1,116 | $15K | |
| 73110 | <1% | 773 | $15K | |
| 90651 | <1% | 445 | $14K | |
| 95911 | <1% | 98 | $12K | |
| 90678 | <1% | 33 | $11K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 1,014 | $11K |
| 90670 | <1% | 668 | $10K | |
| 95908 | <1% | 178 | $10K | |
| 73630 | <1% | 441 | $9K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 196 | $9K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 906 | $9K |
| 0064A | <1% | 162 | $9K | |
| 73100 | <1% | 560 | $9K | |
| 92250 | <1% | 153 | $8K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 52 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 413 | $8K |
| 77080 | <1% | 199 | $7K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 206 | $6K |
| 81025 | <1% | 1,961 | $6K | |
| 82274 | <1% | 347 | $6K | |
| 90682 | <1% | 130 | $6K | |
| 20610 | <1% | 146 | $6K | |
| 90746 | <1% | 189 | $6K | |
| 90734 | <1% | 361 | $6K | |
| 95910 | <1% | 50 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 608 | $5K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 155 | $5K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 347 | $5K |
| 90732 | <1% | 87 | $5K | |
| 73590 | <1% | 239 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 269 | $4K |
| 95885 | <1% | 78 | $4K | |
| 0124A | <1% | 58 | $4K | |
| 73562 | <1% | 185 | $4K | |
| 17110 | <1% | 39 | $4K | |
| 73080 | <1% | 147 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 554 | $3K |
| 0001A | <1% | 58 | $3K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 108 | $3K |
| 81002 | <1% | 5,947 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 44 | $3K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 262 | $3K |
| 95909 | <1% | 32 | $2K | |
| 73090 | <1% | 130 | $2K | |
| 73130 | <1% | 105 | $2K | |
| 86580 | <1% | 626 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 348 | $2K |
| 90662 | <1% | 297 | $2K | |
| 73030 | <1% | 90 | $2K | |
| 77081 | <1% | 105 | $2K | |
| 90480 | <1% | 54 | $2K | |
| 0012A | <1% | 30 | $2K | |
| 90685 | <1% | 250 | $2K | |
| 0969 | <1% | 25 | $1K | |
| 0002A | <1% | 27 | $1K | |
| 96127 | <1% | 317 | $1K | |
| 0004A | <1% | 24 | $1K | |
| 99173 | <1% | 1,688 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 96 | $1K |
| 73070 | <1% | 47 | $896.85 | |
| 90698 | <1% | 90 | $883.53 | |
| 72170 | <1% | 39 | $859.20 | |
| 73000 | <1% | 45 | $829.06 | |
| 72100 | <1% | 40 | $768.17 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 203 | $758.66 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 80 | $747.14 |
| G0466 | Community health center visit, new patient | <1% | 165 | $680.80 |
| 69209 | <1% | 73 | $667.46 | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 49 | $641.59 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 219 | $589.58 |
| 90633 | <1% | 63 | $567.00 | |
| 90680 | <1% | 54 | $486.00 | |
| J3490 | Unclassified drugs | <1% | 15 | $399.00 |
| 0761 | <1% | 13 | $374.33 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 113 | $332.49 |
| 99442 | <1% | 12 | $295.20 | |
| 99188 | <1% | 13 | $280.80 | |
| 99441 | <1% | 14 | $239.83 | |
| 73140 | <1% | 27 | $215.60 | |
| 82948 | <1% | 228 | $199.73 | |
| 90744 | <1% | 29 | $153.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 94 | $5.35 |
| A4649 | Surgical supply; miscellaneous | <1% | 153 | $3.02 |
| 90837 | Psychotherapy session, about an hour | 0% | 421 | $0.00 |
| 91322 | 0% | 27 | $0.00 | |
| 90656 | 0% | 239 | $0.00 | |
| Z1034 | 0% | 913 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 13 | $0.00 |
| 0270 | 0% | 26 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 34 | $0.00 |
| Z7610 | 0% | 38 | $0.00 | |
| 0636 | 0% | 15 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 104 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| County of Ventura | Ventura, CA | $136.15M |
| County of Ventura | Simi Valley, CA | $47.73M |
| County of Ventura | Ventura, CA | $32.44M |
| County of Ventura | Oxnard, CA | $21.57M |
| County of Ventura | Thousand Oaks, CA | $17.77M |
| County of Ventura | Oxnard, CA | $17.55M |
| County of Ventura | Oxnard, CA | $15.99M |
| County of Ventura | Santa Paula, CA | $12.56M |
| County of Ventura | Oxnard, CA | $12.44M |
| County of Ventura | Oxnard, CA | $9.75M |
| County of Ventura | Moorpark, CA | $7.20M |
| County of Ventura | Camarillo, CA | $5.53M |
| County of Ventura | Fillmore, CA | $5.01M |
| County of Ventura | Santa Paula, CA | $3.83M |
| County of Ventura | Oxnard, CA | $618K |
| County of Ventura | Ventura, CA | $380K |
| County of Ventura | Oxnard, CA | $24K |
| County of Ventura | Oxnard, CA | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.